Literature DB >> 12873648

Improving estimates of event incidence over time in populations exposed to other events: application to three large databases.

Corinne Alberti1, Fabien Métivier, Paul Landais, Eric Thervet, Christophe Legendre, Sylvie Chevret.   

Abstract

The Kaplan-Meier (KM) method is commonly used to estimate the incidence of an event over time. It assumes independence between the event of interest and any competing event that precludes the event of interest to occur. However, when the competing event is death without the event of interest, censoring these patients will affect the incidence of the event of interest by modifying the number of exposed patients, so that KM results will be misleading. Three prospective cohorts were studied: (1) 657 renal transplant recipients, (2) 262 children with acute leukemia who received bone marrow transplants, and (3) 8,353 intensive care patients. The main outcome measures were kidney graft loss, leukemia relapse, and ICU-acquired infection, respectively, with death before the main outcome as the competing event. The incidence of each main outcome was overestimated by the KM method. The magnitude of overestimation ranged from 3% to 30%, and varied with baseline patient characteristics and follow-up duration, with most of this variation being related to the rate of the competing event. A competing-risk approach must be used to analyze the risk of events other than death in cohort studies, particularly when mortality rates are high.

Entities:  

Mesh:

Year:  2003        PMID: 12873648     DOI: 10.1016/s0895-4356(03)00058-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

Review 1.  Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.

Authors:  Sarah Lacny; Todd Wilson; Fiona Clement; Derek J Roberts; Peter D Faris; William A Ghali; Deborah A Marshall
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

2.  IMPACT trial results should not change current standard of care of 100 days for cytomegalovirus prophylaxis.

Authors:  A C Kalil; J Sun; D F Florescu
Journal:  Am J Transplant       Date:  2010-11-29       Impact factor: 8.086

3.  Duration of Hemodialysis Following Peritoneal Dialysis Cessation in Australia and New Zealand: Proposal for a Standardized Definition of Technique Failure.

Authors:  Patrick G Lan; Philip A Clayton; David W Johnson; Stephen P McDonald; Monique Borlace; Sunil V Badve; Kamal Sud; Neil Boudville
Journal:  Perit Dial Int       Date:  2016-05-04       Impact factor: 1.756

4.  Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis.

Authors:  Christophe Clec'h; Frédéric Gonzalez; Alexandre Lautrette; Molière Nguile-Makao; Maïté Garrouste-Orgeas; Samir Jamali; Dany Golgran-Toledano; Adrien Descorps-Declere; Frank Chemouni; Rebecca Hamidfar-Roy; Elie Azoulay; Jean-François Timsit
Journal:  Crit Care       Date:  2011-05-17       Impact factor: 9.097

5.  Evaluating mortality in intensive care units: contribution of competing risks analyses.

Authors:  Matthieu Resche-Rigon; Elie Azoulay; Sylvie Chevret
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

6.  Cumulative incidence for wait-list death in relation to length of queue for coronary-artery bypass grafting: a cohort study.

Authors:  Boris G Sobolev; Lisa Kuramoto; Adrian R Levy; Robert Hayden
Journal:  J Cardiothorac Surg       Date:  2006-08-24       Impact factor: 1.637

7.  The risk of death associated with delayed coronary artery bypass surgery.

Authors:  Boris G Sobolev; Adrian R Levy; Lisa Kuramoto; Robert Hayden; James M Brophy; J Mark FitzGerald
Journal:  BMC Health Serv Res       Date:  2006-07-05       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.